Among the multiple comorbidities associated with substance use disorders and injection, hepatitis C (HCV) and chronic non-cancer pain (CNCP) (i.e. intermittent or continuous pain for more than 3 months) are frequent and often coexisting conditions that cause a significant societal burden. The modalities of peer support in these conditions among people who use psychoactive substances by injection have been understudied, particularly in Quebec.
- Characterize the experience of chronic pain among people who inject substances and advance knowledge about the relationship between pain, substance use, and subsequent adverse outcomes.
- Co-construct a peer approach to improve the well-being and engagement in health and care of people who inject substances and are struggling with hepatitis C and/or chronic pain.
- Canadian Institutes of Health Research
- Health Canada
- Ministère de la santé et des services sociaux du Québec
- Institut universitaire sur les dépendances
- CIUSSS du Centre-Sud de l’Île de Montréal